newsfilter
← Latest News
PR Newswire·

Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma's Innovative Drug ARDS-003

Combining ARDS-003 with antiviral drugs significantly decreased viral replication compared to antiviral treatment alone. OTTAWA, ON, June 21, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1),